Bone sarcoma Flashcards
name some high grade sarcoma
synovial sarcoma
osteosarcoma
ewings sarcoma
rhabdomyosarcoma
common sarcoma of head and neck region
rhabdomyosarcoma (child)
angiosarcoma (elderly)
osteogenic sarcoma (jaw)
common skin sarcoma
angiosarcoma
kaposi sarcoma
epithelioid sarcoma
lymphangiosarcoma
dermatofibrosarcoma protuberans
sarcoma that rarely metastasize
Well differentiated liposarcoma
well differentiated fibrosarcoma
malignant fibrous histiocytoma
kaposi sarcoma
paraneoplastic syndrome of sarcoma
hyperglycemia(RPS)
hypertrophic osteoarthropathy
hypocalcemia
oncogenic osteomalacia
common bone sarcoma type
1.chondrogenic:
primary chondrosarcoma
secondary chondrosarcoma
dedifferentiated chondrosarcoma
mesenchymal chondrosarcoma
2. osteogenic
osteosarcoma
parosteal osteogenic sarcoma
3. unknown origin
ewings tumor
malignant GCT
4. fibrogenic
fibrosarcoma
5. notochordal
chordoma
preferred chemotherapy for osteosarcoma
preferred:
Cisplatin and doxorubicin
MAP(high dose methotrexate, cisplatin, doxorubicin)
other
doxorubicin, cisplatin, ifosfamide and high dose methotrexate
2nd line chemotherapy for osteosarcoma
ifosfamide +-etoposide
regorafenib
sorafenib
preferred chemotherapy schedule for ewings sarcoma
VDC/IE
VAIA
VIDE
radiotherapy dose for ewings sarcoma
definitive RT:
45 gy than boost upto 55.8 gy
preoperative RT
36-45 gy for initial GTV+ 2cm
post operative RT
R0= 45gy
R1=45 (nccn)
R2= 45–boost upto 55.8gy
radiotherapy dose for osteosarcoma
consider RT for positive margin or gross residual disease R2
post op RT: 55 gy
unresectable disease: 66-70 gy
Prognostic factors for bone sarcoma
Size and extent of local spread
Grade
Location
Size and three dimensions of tumor size
Stage
Mets site
Histologic response to chemo
Pathological fracture
Bone sarcoma RT complication
Acute
skin erythema, discoloration
Pain
Swelling
Late
Abnormal bone and soft tissue growth and development,
permanent weakening of the affected bone,
scoliosis,
decreased range of motion due to fibrosis or joint involve- ment,
vascular changes resulting in greater sensitivity to infection,
fracture,
lymphedema,
skin discoloration or tel- angiectasia,
osteoradionecrosis
2nd malignancy: leukemia